PodParley PodParley
PodParley
Andres Cervantes, MD, PhD, Discusses Trastuzamab Deruxtecan as Emerging Therapy for Gastric Cancer episode artwork

EPISODE · Jan 18, 2021 · 3 MIN

Andres Cervantes, MD, PhD, Discusses Trastuzamab Deruxtecan as Emerging Therapy for Gastric Cancer

from Oncology Learning Network · host HMP Global

Dr Cervantes highlights the significance of the DESTINY-Gastric01 trial and new advancements in treatment of HER2+ gastric cancer.

Episode metadata supplied by the publisher feed · Published Jan 18, 2021

Embed this episode

Ready to play

Andres Cervantes, MD, PhD, Discusses Trastuzamab Deruxtecan as Emerging Therapy for Gastric Cancer

0:00 3:23

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Oncology Learning Network?

This episode is 3 minutes long.

When was this Oncology Learning Network episode published?

This episode was published on January 18, 2021.

Can I download this Oncology Learning Network episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!